Subscribe

Brian Till, MD

Articles by Brian Till, MD

Dr. Till on the Potential to Utilize CAR T-Cell Therapy Earlier in MCL

ByBrian Till, MD

March 4th 2021

Brian Till, MD, discusses the potential to utilize CAR T-cell therapy earlier in the treatment of patients with mantle cell lymphoma.

Latest Updated Articles

Trending on CGTlive®

PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data

Data Roundup: October 2025 Features Updates from ESMO, ESGCT, and More

© 2025 MJH Life Sciences^®

All rights reserved.